Citation: | HERong-rong, LYUXiang, ZHOUJing, MAHong-yue, YANYan-qing, WANGHeng-bin, DILiu-qing, DUANJin-ao. Evaluation on Realgar Safety and Reducing Toxicity[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(6): 645-648. |
[1] |
李时珍. 本草纲目[M]. 北京: 中医古籍出版社,2013: 56-57.
|
[2] |
SHEN S, LI XF, CULLEN WR, et al. Arsenic binding to proteins[J]. Chem Rev, 2013, 113(10): 7769-7792.
|
[3] |
GENG W, KOMINE R, OHTA T, et al. Arsenic speciation in marine product samples: comparison of extraction-HPLC method and digestion-cryogenic trap method[J]. Talanta, 2009, 79(2): 369-375.
|
[4] |
MA R, SHEN J, WU J, et al. Impact of agronomic practices on arsenic accumulation and speciation in rice grain[J]. Environ Pollut, 2014, 194: 217-223.
|
[5] |
ZHAO FJ, STROUD JL, EAGLING T, et al. Accumulation, distribution, and speciation of arsenic in wheat grain[J]. Environ Sci Technol, 2010, 44(14): 5464-5468.
|
[6] |
NEARING MM, KOCH I, REIMER KJ. Arsenic speciation in edible mushrooms[J]. Environ Sci Technol, 2014, 48(24): 14203-14210.
|
[7] |
ZHOU J,MA H,WU Y, et al. Lipidomic profiling of subchronic As4S4 exposure identifies inflammatory mediators as sensitive biomarkers in rats[J]. Metallomics,2018,DOI: 10.1039/C8MT00181B.
|
[8] |
吴倩. 砷元素分析方法研究及其在六神丸安全性再评价中的应用[D]. 北京:清华大学,2007.
|
[9] |
LIU J, LU Y, WU Q, et al. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite[J]. J Pharmacol Exp Ther, 2008, 326(2): 363-368.
|
[10] |
RODRIGUEZ VM, DEL R L, LIMON-PACHECO JH, et al. Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver[J]. Toxicol Sci, 2005, 84(1): 157-166.
|
[11] |
NARANMANDURA H, IBATA K, SUZUKI KT. Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells[J]. Chem Res Toxicol, 2007, 20(8): 1120-1125.
|
[12] |
BACH SJ. Biological methylation[J]. Biol Rev Camb Philos Soc. 1945, 20: 158-176.
|
[13] |
SUZUKI KT, KATAGIRI A, SAKUMA Y, et al. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats[J]. Toxicol Appl Pharmacol, 2004, 198(3): 336-344.
|
[14] |
YAMANAKA K, MIZOI M, TACHIKAWA M, et al. Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol[J]. Toxicol Lett, 2003, 143(2): 145-153.
|
[15] |
SUZUKI KT, TOMITA T, OGRA Y, et al. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats[J]. Chem Res Toxicol, 2001, 14(12): 1604-1611.
|
[16] |
HAYAKAWA T, KOBYASHI Y, CUI X, et al. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19[J]. Arch Toxicol, 2005, 79(4): 183-191.
|
[17] |
TEMPLETON D, ARIESE F, CORNELIS R, et al. Guidelines for terms related to chemical speciation and fractionation of elements. Definitions, structural aspects, and methodological approaches (IUPAC Recommendations 2000)[J]. Pure Appl Chem,2000,72(8): 1453-1470.
|
[18] |
HUGHES MF. Arsenic toxicity and potential mechanisms of action[J]. Toxicol Lett, 2002, 133(1): 1-16.
|
[19] |
安艳,李春春,邓晗依. 砷诱发氧化应激研究现状[J]. 国外医学(医学地理分册), 2015, 36(03): 165-173.
|
[20] |
GOMEZ SE, DEL RAZO LM, MUNOZ SANCHEZ JL. Induction of DNA damage by free radicals generated either by organic or inorganic arsenic (AsⅢ, MMAⅢ and DMAⅢ) in cultures of B and T lymphocytes.[J]. Biologic Trace Element Res, 2005, 108(1):115-126.
|
[21] |
陆远富,时京珍,石京山,等. 科学评价含雄黄、朱砂中成药的安全性[J]. 中国中药杂志, 2011, 36(24): 3402-3405.
|
[22] |
XIE T, ZHOU X, WANG S, et al. Development and application of a comprehensive lipidomic analysis to investigate Tripterygium wilfordii-induced liver injury[J]. Anal Bioanal Chem, 2016, 408(16): 4341-4355.
|
[23] |
TAM VC, QUEHENBERGER O, OSHANSKY CM, et al. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation[J]. Cell, 2013, 154(1): 213-227.
|
[24] |
O'CONNELL TM, WATKINS PB. The application of metabonomics to predict drug-induced liver injury[J]. Clin Pharmacol Ther, 2010, 88(3): 394-399.
|
[25] |
王佳佳.六神丸组方配伍对大鼠肝脏重金属砷水平和炎症磷脂的影响[D].南京:南京中医药大学, 2017.
|
[26] |
周超凡, 林育华.传统中药雄黄应用概况及其安全性[J].药物不良反应杂志, 2008, 10(3):184-189.
|
[27] |
陈丽娜, 吴丽兰. 67例牛黄解毒丸(片)不良反应分析[J].中国中药杂志, 2002, 27(4):315.
|
[28] |
贾小靖. 六神丸治疗带状疱疹22例疗效分析[J].临床医药实践, 2013,22(5): 391-392.
|
[29] |
张庆丽,吴倩,谢媛媛,等.六神丸和雄黄中砷的组织分布研究[J].药学学报, 2011,46(6): 701-706.
|
[30] |
张庆丽, 吴倩, 谢媛媛,等.六神丸和雄黄中砷的毒代动力学研究[J].毒理学杂志, 2011,25(5): 332-335.
|